Competing interests
Alzheimer’s Disease Consortium (EADC), ZB
GW, ZB, and MG are full-time employees of Boehringer Ingelheim. GW and ZB have received financial support for travel from Boehringer Ingelheim. FJ is an employee of Klinik und Poliklinik für Psychiatrie und Psychotherapie and has received consulting fees from AbbVie, Biogen, Boehringer Ingelheim, Danone, Eisai, GE Healthcare, Green Valley, Hummingbird Bioscience, MSD, OM Pharma, Vifor Pharma, Roche, and Janssen. In addition, FJ has received payment for presentations and advisory boards from AC Immune, Eli Lilly, Janssen, and Roche; has performed contracted research for Boehringer Ingelheim; and is on the executive board of the German Psychiatric Association (DGPPN) and the European Alzheimer’s Disease Consortium (EADC). Medical writing support was provided by Lisa Auker, PhD, and Lesley Blogg, PhD, of Fishawack Communications Ltd., part of Fishawack Health, and was funded by Boehringer Ingelheim GmbH.